Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Hendrix

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Antimicrobial Agents and Chemotherapy|March 1, 1993
Biologic effects after a single dose of poly(I):poly(C12U) in healthy volunteersC W Hendrix, J B Margolick, B G Petty, et al.
Journal of Acquired Immune Deficiency Syndromes|January 11, 1992
Comparison by race of total serum IgG, IgA, and IgM with CD4+ T-cell counts in North American persons infected with the human immunodeficiency virus type 1D R Lucey, C W Hendrix, C Andrzejewski, et al.
Viral Immunology|January 1, 1990
Hepatitis C antibody in a non-hemophiliac cohort infected with the human immunodeficiency virusD R Lucey, C W Hendrix, C Andrzejewski, et al.
Antiviral Research|October 1, 1995
Modulation of alpha-interferon's antiviral and clinical effects by aspirin, acetaminophen, and prednisone in healthy volunteersC W Hendrix, B G Petty, A Woods, et al.
The Journal of Infectious Diseases|October 1, 1992
Reconstitution of long-term T helper cell function after zidovudine therapy in human immunodeficiency virus-infected patientsM Clerici, A L Landay, H A Kessler, et al.
Viral Immunology|January 1, 1993
Cerebrospinal fluid neopterin levels in 159 neurologically asymptomatic persons infected with the human immunodeficiency virus (HIV-1): relationship to immune statusD R Lucey, S A McGuire, S Abbadessa, et al.
Journal of Virology|September 1, 1992
Examination of sera from human immunodeficiency virus type 1 (HIV-1)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of HIV-1 gp120 and for in vitro neutralizing activityR Q Warren, S A Anderson, W M Nkya, et al.
The Journal of Infectious Diseases|December 1, 1991
Human immunodeficiency virus reverse transcriptase T helper epitopes identified in mice and humans: correlation with a cytotoxic T cell epitopeA S De Groot, M Clerici, A Hosmalin, et al.
Journal of Acquired Immune Deficiency Syndromes|September 1, 1993
Measurement of cerebrospinal fluid antibody to the HIV-1 principal neutralizing determinant (V3 loop)D R Lucey, T C VanCott, L D Loomis, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 1994
Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesisM Clerici, A Sarin, R L Coffman, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|March 1, 1993
Biologic effects after a single dose of poly(I):poly(C12U) in healthy volunteersC W Hendrix, J B Margolick, B G Petty, et al.
Journal of Acquired Immune Deficiency Syndromes|January 11, 1992
Comparison by race of total serum IgG, IgA, and IgM with CD4+ T-cell counts in North American persons infected with the human immunodeficiency virus type 1D R Lucey, C W Hendrix, C Andrzejewski, et al.
Viral Immunology|January 1, 1990
Hepatitis C antibody in a non-hemophiliac cohort infected with the human immunodeficiency virusD R Lucey, C W Hendrix, C Andrzejewski, et al.
Antiviral Research|October 1, 1995
Modulation of alpha-interferon's antiviral and clinical effects by aspirin, acetaminophen, and prednisone in healthy volunteersC W Hendrix, B G Petty, A Woods, et al.
The Journal of Infectious Diseases|October 1, 1992
Reconstitution of long-term T helper cell function after zidovudine therapy in human immunodeficiency virus-infected patientsM Clerici, A L Landay, H A Kessler, et al.
Viral Immunology|January 1, 1993
Cerebrospinal fluid neopterin levels in 159 neurologically asymptomatic persons infected with the human immunodeficiency virus (HIV-1): relationship to immune statusD R Lucey, S A McGuire, S Abbadessa, et al.
Journal of Virology|September 1, 1992
Examination of sera from human immunodeficiency virus type 1 (HIV-1)-infected individuals for antibodies reactive with peptides corresponding to the principal neutralizing determinant of HIV-1 gp120 and for in vitro neutralizing activityR Q Warren, S A Anderson, W M Nkya, et al.
The Journal of Infectious Diseases|December 1, 1991
Human immunodeficiency virus reverse transcriptase T helper epitopes identified in mice and humans: correlation with a cytotoxic T cell epitopeA S De Groot, M Clerici, A Hosmalin, et al.
Journal of Acquired Immune Deficiency Syndromes|September 1, 1993
Measurement of cerebrospinal fluid antibody to the HIV-1 principal neutralizing determinant (V3 loop)D R Lucey, T C VanCott, L D Loomis, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 1994
Type 1/type 2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesisM Clerici, A Sarin, R L Coffman, et al.
Pageof 6